Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Mursaloglu (Istanbul, Turkey), C. Akin (Istanbul, Turkey), C. Yilmaz (Istanbul, Turkey), P. Ergenekon (Istanbul, Turkey), Y. Gokdemir (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), F. Karakoc (Istanbul, Turkey), A. Karahasan (Istanbul, Turkey), B. Karadag (Istanbul, Turkey). Predictors of eradication failure at first isolation of MRSA in cystic fibrosis patients. 692

Member's Comments

No comment yet.

Related content which might interest you: The efficacy of early eradication therapy in prevention of chronic pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 486s Year: 2006 Survey of microbiology, pseudomonas eradication and antimicrobial prophylaxis in adult patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Audit on the MRSA infection in adults with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Pseudomonas aeruginosa in patients with cystic fibrosis - a comparison of early eradication and conventional therapy Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment? Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 342s Year: 2002 Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Long-term evaluation of the response to aggressive treatment at the first colonization of P.aeruginosa in cystic fibrosis (CF) Source: Eur Respir J 2001; 18: Suppl. 33, 126s Year: 2001 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 DNA fingerprinting of pseudomonas aeruginosa in cystic fibrosis patients: risk assessment of cross-infection in a CF centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Antibiotic treatment of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 188-202 Year: 2014 MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis Source: ERJ Open Res 2016 Year: 2016 Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Successful eradication of methicillin-resistant staphylococcus aureus in chronically colonized cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Emerging pathogens in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66 Year: 2006 Prevalence of hyperglycaemia during infective exacerbation in adult cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Eradication regime of methicillin resistant staphylococcus aureus lung infection in cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis Source: Eur Respir J, 57 (5) 2003636; 10.1183/13993003.03636-2020 Year: 2021 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002